Skip to main content ↑ ↓
Topic: The Uncertain Path Forward for Psychedelic Medicine (Read 106 times) previous topic - next topic

The Uncertain Path Forward for Psychedelic Medicine

The Uncertain Path Forward for Psychedelic Medicine

[html]After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff and its founder has left the co*pany.[/html]

Source: The Uncertain Path Forward for Psychedelic Medicine (http://ht**://www.wired.c**/story/where-does-psychedelic-assisted-therapy-go-next-mdma-fda-lykos/)